Delivery Order SPE2DB22D3501-SPE2DB23FWJ06
Award Date 7/11/23
Potential Completion Date 8/1/23
Potential Value $28K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,122.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561750571 REVLIMID 10 MG CAPSULE 28S. This order was placed under an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the specified pharmaceutical to its Conshohocken, Pennsylvania facility by August 29, 2023 to support DOD health programs. No set...
- The Defense Logistics Agency awarded a $56,490.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical Revlimid 10 mg. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is from August 18, 2023 through September 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's mission to provide critical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $28,245.28 to Amerisourcebergen Drug Corporation for the provision of 4561508525 REVLIMID 10 MG CAPSULE 28S. The contract has a period of performance from July 13, 2023 through August 3, 2023, with all work to be conducted by the prime contractor at its facility located in Conshohocken, Pennsylvania. This delivery order was issued against an existing DLA vehicle to support the procurement of pharmaceutical...
- The Defense Logistics Agency awarded a $14,122.63 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical Revlimid 10 mg. The order is being fulfilled under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the Revlimid capsules to a facility in Conshohocken, Pennsylvania by September 12, 2023 to support DLA and DoD medical readiness...
- The Defense Logistics Agency awarded a $157,346 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 100 capsules of the pharmaceutical Revlimid 5 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one month period concluding in mid-October 2023. No...
- The Defense Logistics Agency awarded a delivery order valued at $82,961.12 to Amerisourcebergen Drug Corporation for the provision of 4561312422 REVLIMID 10 MG CAPSULE 28S. The firm fixed price order calls for the delivery of pharmaceutical products to a location in Conshohocken, Pennsylvania by July 13, 2023 in support of Department of Defense requirements. Amerisourcebergen will serve as the prime contractor on this delivery order placed against an unspecified governmentwide acquisition...
- The Defense Logistics Agency awarded a $14,122 delivery order to Amerisourcebergen Drug Corporation for 4562106623 REVLIMID 10 MG CAPSULE 28S. The firm fixed price order is being fulfilled under an existing Prime Vendor Pharmaceutical contract vehicle and will provide the specified pharmaceutical products to DLA from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Performance will take place between September 8 and September 29, 2023. No set aside designation or subcontractors were...
- The Defense Logistics Agency awarded a $215,824.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561924650 REVLIMID 10 MG CAPSULE 100S. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility in performance of the contract through September 13, 2023. The Defense Logistics Agency supports Department of Defense procurement programs by sourcing medical supplies and pharmaceuticals....
- The Defense Logistics Agency awarded a $42,368 delivery order to Amerisourcebergen Drug Corporation for the supply of 4562224020 REVLIMID 10 MG CAPSULE 28S. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to provide pharmaceutical products in support of DLA and DoD health programs. Performance will take place in Conshohocken, Pennsylvania over a one month period concluding in early October 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a delivery order valued at $373,171.40 to Amerisourcebergen Drug Corporation for the provision of 4562106624 REVLIMID 10 MG CAPSULE 100S. The firm fixed price order calls for the delivery of pharmaceutical products to a facility located in Conshohocken, Pennsylvania by September 29, 2023 in support of Department of Defense requirements. Amerisourcebergen will serve as the prime contractor on the order placed under an unspecified multiple award contract...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWJ06Delivery Order
The Defense Logistics Agency awarded a $28,245 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 28 capsules of the pharmaceutical REVLIMID 10 MG. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on August 1, 2023. No set aside designation or subcontractors were identified. This order supports DLA's mission to provide medical supplies and medications to military treatment facilities worldwide.
Generated 12/19/23, 9:39 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.2k | 7/11/23 |